NGM Bio Holdings
NGM Bio Holdings is a startup headquartered in South San Francisco, United States, founded in 2024. It has raised at least $142.0m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the growth stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
NGM Bio Holdings has raised at least $142.0m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
NGM Bio Holdings sits inside the Silicon Valley and the Bay Area R&D ecosystem in the Global R&D Labs Directory.
Other startups in South San Francisco
- Addition Therapeutics
- Asher Biotherapeutics
- Burnbot
- Dualitas Therapeutics
- Firefly Bio
- Kamau Therapeutics
- Long Bridge Medical
- Lycia Therapeutics
- Mahzi Therapeutics
- Moonwalk Biosciences
- NewLimit
Related
- Innovation profile of South San Francisco
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does NGM Bio Holdings do?
NGM Bio Holdings is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has NGM Bio Holdings raised?
At least $142.0m, according to its Form D filings with the US Securities and Exchange Commission.
Where is NGM Bio Holdings based?
NGM Bio Holdings is headquartered in South San Francisco, United States.
When was NGM Bio Holdings founded?
NGM Bio Holdings was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.